Walter Kleptko of Vienna Medical University, Vienna, Austria, gives an exciting talk on the current state and future of lung transplantation.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
May 11, 2016
This is a very interesting study. The authors tried to find if the weekend effect would affect the outcomes of both elective surgery and urgent surgery (cardiac and non-cardiac surgery). This retrospective study enrolled more than 300K patients undergoing surgery including CABG.
May 11, 2016
Bob Replogle, the driving force behind the creation of CTSNet, died on Monday, May 9. CTSNet Co-Editor Mark Ferguson pays tribute to his life and his lasting impact on the specialty.
May 10, 2016
This video demonstrates a robotic lobectomy through a subxiphoid approach.
May 8, 2016
The entire issue is dedicated to thrombosis and makes a compulsory read for cardiovascular and thoracic hospitalists. Of patricular relevance to the thoracic surgeon are the translational articles on system analysis (page 1348) and the table on oral anticoagulants on page 1410.
May 5, 2016
The goal of this multicenter survey was to determine the psychological and social impact of incidental pulmonary nodule detection.
May 5, 2016
The FDA is assuming regulatory control over e-cigarettes. Sales of e-cigarettes will be banned to those <18 years old. In addition, warning labels will be required on all packages and all products are now subject to government approval.
May 5, 2016
This is an outstanding and provocative editorial comment concerning treatment costs of lung cancer based on an article published in the last issue of the European Respiratory Journal. It reveals discrepancies in access to new therapies based on therapeutic targets due to molecular testing and treatment costs.
May 5, 2016
In this multicenter study, baseline QOL was assessed in over 200 patients with stage II or III esophageal cancer who underwent induction therapy and surgery or definitive chemoradiotherapy. Baseline QOL was related to survival independent of age, stage, histologic type, and treatment. It is suggested that assessment of baseline QOL is a prognostic
May 4, 2016
Pierre-Emmanuel Falcoz of Nouvel Hôpital Civil, Strasbourg, France, discusses the use of ECMO in thoracic surgery.